Esperion Therapeutics, Inc. · NASDAQ:ESPR

Halladay Benjamin sold 10,773 Esperion Therapeutics, Inc. shares (Form 4)

Traded Jun 17, 2026 · Filed Jun 18, 2026

On Jun 17, 2026, Halladay Benjamin (Chief Financial Officer) sold 10,773 Esperion Therapeutics, Inc. shares at US$3.16 for US$34,043, leaving 702,829 shares. Filed Jun 18, 2026 (Form 4).

Sold
10,773 shares
Price
US$3.16
Value
US$34,043
Holding after
702,829 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 17, 2026Common StockSale10,773US$3.16702,829Direct

Source

View original at SEC

Related